Development of an easy and quick serodiagnostic method for important parasitosis using geratine particles coated with recombinant parasite antigens
使用涂有重组寄生虫抗原的吉拉汀颗粒开发一种简单快速的重要寄生虫病血清诊断方法
基本信息
- 批准号:07557206
- 负责人:
- 金额:$ 3.2万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1996
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Schistosomiasis japonicum is one of the important infectious diseases in the world which is endemic mainly in China and Philippines. Up to now, there are some diagnostic methods such as ELISA,IHA,and IFAT etc. However, these need special reagents, expensive instruments, and skillful techniques. Therefore, they can not be used widely in the endemic fields. To resolve these problems, we tried to develop a novel, easy, and quick serodiagnostic method using by gelatin particles coated with recombinant parasite antigens.We successed to analyze a whole cDNA sequence of Schistosoma japonicum adult antigen recognized by SJA111 mAb, established in our department. The cDNA sequence was almost the same as a known one, except 4 base pairs. However, there is a no report about this recombinant protein. Therefore, we produced the recombinant proteins from BL21 (DE3) E.coli transformed with Pet23b-SJAcDNA.The recombinant proteins were purified with an affinity column, subjected to SDS 12% PAGE,and immunoblotted with SJA111 mAb. The recombinant proteins reacted with SJA111 mAb. Therefore, we produced and purified in a small scale the recombinant proteins recognized by SJA111 mAb. We are now trying to obtain large amounts of purified recombinant proteins. And then, we will check whether the gelatin particles coated with the purified recombinant proteins are useful tool or not for serodiagnosis of schistosomiasis japonicum by using patient sera of many kinds of parasitosis, including schistosomiasis, from Laos.
日本血吸虫病是世界性的重要传染病之一,主要流行于中国和菲律宾。目前的诊断方法有ELISA、IHA、IFAT等,但这些方法需要特殊的试剂、昂贵的仪器和熟练的技术。因此,它们不能广泛应用于地方病领域。为了解决这些问题,我们尝试建立了一种新的、简便、快速的血清学诊断方法-该cDNA序列与已知的cDNA序列基本相同,只有4个碱基对不同。然而,目前还没有关于该重组蛋白的报道。因此,我们用Pet 23 b-SJAcDNA转化BL 21(DE 3)大肠杆菌,获得重组蛋白,用亲和层析柱纯化,SDS12%PAGE电泳,用SJA 111单克隆抗体进行免疫印迹。重组蛋白与SJA 111单抗反应。因此,我们在小规模生产和纯化的重组蛋白识别的SJA 111单克隆抗体。我们现在正在努力获得大量纯化的重组蛋白。然后,我们将检查是否与纯化的重组蛋白包被的明胶颗粒是有用的工具或不使用多种寄生虫病,包括血吸虫病,从老挝的患者血清,日本血吸虫病的血清诊断。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SENDO Fujiro其他文献
SENDO Fujiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SENDO Fujiro', 18)}}的其他基金
Molecular immunological analysis of early resistance existed in susceptible mice to protozoan infection.
分子免疫学分析表明易感小鼠对原虫感染存在早期抵抗力。
- 批准号:
11470064 - 财政年份:1999
- 资助金额:
$ 3.2万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A study on involvement of cytokines in immune response to parasite infections using immune response-reacted gene defective mice
使用免疫反应反应基因缺陷小鼠研究细胞因子参与寄生虫感染免疫反应
- 批准号:
07457066 - 财政年份:1995
- 资助金额:
$ 3.2万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Monoclonal Antibodies as a Diagnostic Tool for Helminth Infection
单克隆抗体作为蠕虫感染的诊断工具
- 批准号:
01480170 - 财政年份:1989
- 资助金额:
$ 3.2万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
Development of an innovative recombinant protein vaccine against Aeromonas veronii in European seabass using "omics" technologies (AeroVeroVacc)
使用“组学”技术开发针对欧洲鲈鱼维氏气单胞菌的创新重组蛋白疫苗 (AeroVeroVacc)
- 批准号:
EP/Y026454/1 - 财政年份:2024
- 资助金额:
$ 3.2万 - 项目类别:
Fellowship
I-Corps: Accelerating recombinant protein screening
I-Corps:加速重组蛋白筛选
- 批准号:
2328626 - 财政年份:2023
- 资助金额:
$ 3.2万 - 项目类别:
Standard Grant
Integrating data intelligence and hybrid modelling to develop continuous CHO cell lines for recombinant protein production
整合数据智能和混合建模来开发用于重组蛋白生产的连续 CHO 细胞系
- 批准号:
2898720 - 财政年份:2023
- 资助金额:
$ 3.2万 - 项目类别:
Studentship
Quantum-Accelerated Recombinant Protein Drug Embedding Frameworks (QARPDEF)
量子加速重组蛋白药物嵌入框架 (QARPDEF)
- 批准号:
10082522 - 财政年份:2023
- 资助金额:
$ 3.2万 - 项目类别:
Small Business Research Initiative
Effect of recombinant protein expression on baculovirus budded virus structure and infectivity
重组蛋白表达对杆状病毒芽胞病毒结构和感染性的影响
- 批准号:
ST/Y000498/1 - 财政年份:2023
- 资助金额:
$ 3.2万 - 项目类别:
Research Grant
Greener, more sustainable platforms for high-value recombinant protein production
更环保、更可持续的高价值重组蛋白生产平台
- 批准号:
EP/X025926/1 - 财政年份:2023
- 资助金额:
$ 3.2万 - 项目类别:
Research Grant
ProNaGen: Engineering of Recombinant Protein Nanosheet-Based Bioemulsions for Next Generation Bioprocessing and Biomanufacturing
ProNaGen:用于下一代生物加工和生物制造的基于重组蛋白纳米片的生物乳液的工程
- 批准号:
EP/Y032667/1 - 财政年份:2023
- 资助金额:
$ 3.2万 - 项目类别:
Research Grant
Novel recombinant protein immunoassays for the diagnosis and monitoring of toxocariasis in children living in the United States.
用于诊断和监测美国儿童弓蛔虫病的新型重组蛋白免疫分析。
- 批准号:
10742436 - 财政年份:2023
- 资助金额:
$ 3.2万 - 项目类别:
Large Scale Expansion of Mesenchymal Stromal Cells using Dissolvable Microcarriers and Animal Product Free Recombinant Protein Coatings
使用可溶性微载体和无动物产品的重组蛋白涂层大规模扩增间充质基质细胞
- 批准号:
569481-2022 - 财政年份:2022
- 资助金额:
$ 3.2万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Generation of Syn-PG1 expressing yeast and the recombinant protein production
表达 Syn-PG1 的酵母的产生和重组蛋白的生产
- 批准号:
571827-2022 - 财政年份:2022
- 资助金额:
$ 3.2万 - 项目类别:
University Undergraduate Student Research Awards